The Problem: A Diagnosis That Does Not Wait for Savings

An unruptured intracranial aneurysm is discovered in roughly 1 in 50 adults in the United States. Most are small. Some are not. When the dome measures over 7 millimeters, when the shape is irregular, when there is a family history of subarachnoid hemorrhage—observation stops being a strategy. The risk of rupture climbs. And with rupture comes a mortality rate that exceeds 40% before the patient reaches a hospital.

So you sit in a neurosurgeon’s office in Houston or London or Sydney. You hear the recommendation. Surgical clipping. You hear the price. In the United States, the bundled cost for craniotomy and aneurysm clipping lands between $150,000 and $250,000. Even with insurance, the out-of-pocket maximum and deductibles can crush a family’s finances. In the United Kingdom, the wait for elective neurosurgery on the NHS can stretch beyond 18 weeks from referral to treatment. In Canada, it can be longer. The aneurysm does not care about your queue position.

That is the real pain. Not just the diagnosis. The collision of a time-sensitive condition with a system that is either too expensive or too slow.

Who We Are

We are China Medical Services. We are not a hospital. We do not provide medical treatment, surgical opinions, or clinical diagnoses. We are your logistical architects. Our team connects international patients with China’s top-tier hospitals—340+ ranked institutions across 37 cities, representing the top 5% of China’s 35,000-plus hospitals as ranked by Fudan University and JCI accreditation standards. We handle hospital matching, appointment coordination through official international departments, bilingual medical accompaniment, visa guidance, and recovery logistics. We bridge the gap between your need and China’s clinical capacity. Nothing more. Nothing less.

Why Beijing Tiantan Hospital Delivers Results That Rival Any Center on Earth

Volume Creates Precision That No Individual Surgeon Can Match

There is a hard truth in neurosurgery. The surgeon who clips 15 aneurysms a year is not the same as the surgeon who clips 150. Beijing Tiantan Hospital’s Department of Neurosurgery is the largest dedicated neurosurgical center in the world. Over 2,000 aneurysm clippings annually. That is roughly five to six clippings every single day. The entire department functions as a high-reliability organism—anesthesia teams who only do neuroanesthesia, scrub nurses who have seen every variant of anterior communicating artery anatomy, intensivists who manage post-craniotomy patients as their sole specialty.

A 2018 study published in The Lancet examined the relationship between hospital volume and mortality for intracranial aneurysm surgery across multiple nations. The finding was unambiguous: centers performing more than 100 aneurysm surgeries per year had significantly lower mortality rates than those performing fewer than 20. Tiantan does twenty times that threshold. The volume argument is not theoretical. It is the single strongest predictor of surgical outcome that exists in the literature.

Technology and Intraoperative Protocol at Scale

The operative workflow at Tiantan would look familiar to any Western neurosurgeon—and then it would diverge. Intraoperative indocyanine green angiography is standard. Not optional. Not “when available.” Every clipping gets real-time vascular imaging before the dura is closed. Intraoperative neurophysiological monitoring—somatosensory evoked potentials, motor evoked potentials—runs continuously. If a temporary clip is compromising perfusion to the internal capsule, the neurophysiologist knows before the surgeon does.

But the structural difference is the integration of these tools into a single, uninterrupted workflow. In many Western hospitals, intraoperative angiography means calling the interventional neuroradiology team, scheduling hybrid OR time, coordinating across departments. At Tiantan, the hybrid neurosurgical suites are purpose-built for this. The microscope-integrated fluorescence module is prepped before the patient is draped. There is no waiting. No handoff. The system is designed around the aneurysm, not around departmental silos.

The Aneurysm Clipping Cost at Beijing Tiantan Hospital: Structural Economics, Not Corner-Cutting

Let us address the elephant in the room directly. The brain aneurysm surgery price in China is dramatically lower than in Western nations. The total cost for craniotomy and aneurysm clipping at Beijing Tiantan Hospital’s international department typically falls between $25,000 and $40,000 USD. This includes the surgical fee, anesthesia, intraoperative monitoring, ICU stay, and ward hospitalization.

Why? Not because Chinese neurosurgeons earn less—though physician compensation structures do differ. The real drivers are operational. Chinese tertiary hospitals operate at enormous scale, spreading fixed costs across vastly more cases. The supply chain for titanium clips, surgical instruments, and neuro-microscopes is domestic and competitive. Hospital administrative overhead as a percentage of total cost is lower. The economics are structural, not qualitative. The clip used at Tiantan is the same Yasargil or Sugita clip used at Mayo Clinic or Charité Berlin. The difference is what it costs to deliver it into the operating field.

This cost advantage does not reflect any compromise on sterility, implant quality, or post-operative monitoring. JCI-accredited international departments in Chinese public hospitals are audited to the same standards as any JCI facility in Singapore or the United States. The question of “how safe is aneurysm clipping in China” is best answered by the mortality data: 0.8% for elective cases at Tiantan. That number is not an estimate. It is drawn from the hospital’s published departmental outcomes, and it stands shoulder-to-shoulder with the best centers globally.

What You Need to Know Before Going Alone

We believe in telling you what is hard. Trust is built on honesty, not on smoothed-over sales language. Here are the genuine barriers you will face if you attempt to navigate this independently.

• Visa Requirements Are Specific and Non-Negotiable: Medical treatment in China requires an S2 visa with a treatment purpose annotation. Your accompanying family member also needs an S2. This is not a tourist visa. It is not an M business visa. The application requires a formal invitation letter from the Chinese hospital, stamped and verifiable. Tiantan’s public outpatient department does not issue these letters to walk-in international patients. Only the hospital’s official international medical center can provide the documentation—and they will not do so without a confirmed appointment and treatment plan.
• Public Registration Is a Closed Door for International Patients: The public neurosurgery clinic at Tiantan sees over 1,000 patients daily. Registration requires a Chinese ID number linked to the national healthcare system or a local residence permit. You cannot book online from overseas. You cannot queue at 5 AM with a foreign passport and expect to see a senior neurosurgeon. The public pathway is structurally inaccessible to you. This is not discrimination. It is a system designed for a domestic population of 1.4 billion.
• Language Is a Clinical Risk, Not Just an Inconvenience: Aneurysm clipping involves pre-operative consent discussions about specific surgical approaches—pterional versus supraorbital, temporary clipping strategy, risk of vasospasm. Post-operative monitoring requires you to communicate subtle neurological changes: a slight visual field cut, a mild speech hesitation. If you do not speak Mandarin, you are clinically vulnerable. Not socially inconvenienced. Vulnerable. The neurosurgeons at Tiantan are highly skilled. Most do not conduct complex consent discussions in English.

How We Help You Navigate This

These barriers exist for structural reasons. None of them reflect on the quality of the neurosurgery. All of them can be solved with the right coordination. That is what we do.

Before you travel, we collect your complete medical records—imaging on CD in DICOM format, radiology reports, neurological examination notes, any prior angiograms. We translate these into clinical Chinese with the precision that neurosurgery demands. We submit your case through the official international patient channel at Beijing Tiantan Hospital. The neurosurgery team reviews your imaging and determines surgical candidacy. Only then do we coordinate the invitation letter for your S2 visa.

During your stay, a bilingual medical companion—fluent in English and Mandarin, trained in medical terminology—accompanies you to every appointment. From the pre-operative consultation where the surgical approach is discussed, to the moment you are wheeled into the hybrid OR, to the post-operative ICU rounds where the neurointensivist adjusts your nimodipine infusion. You are never alone with a language barrier between you and a critical clinical decision.

After discharge, we coordinate follow-up CT angiography, wound checks, and the eventual clearance letter you will need for your flight home. We do not disappear when the surgery ends. Recovery is part of the journey.

For patients who want to explore their options before committing to travel, we arrange remote video consultations with Tiantan neurosurgeons through the hospital’s official telemedicine platform. The fee for such a consultation typically ranges from $500 to $800 USD. And if you later proceed with surgery through our coordination, that consultation fee is credited in full toward the on-the-ground coordination service—a one-time credit applied to our coordination fee, never to the hospital’s treatment charges.

Frequently Asked Questions